AU575617B2 - Collagen coated vascular synthetic graft drug delivery system - Google Patents

Collagen coated vascular synthetic graft drug delivery system

Info

Publication number
AU575617B2
AU575617B2 AU38196/85A AU3819685A AU575617B2 AU 575617 B2 AU575617 B2 AU 575617B2 AU 38196/85 A AU38196/85 A AU 38196/85A AU 3819685 A AU3819685 A AU 3819685A AU 575617 B2 AU575617 B2 AU 575617B2
Authority
AU
Australia
Prior art keywords
delivery system
drug delivery
collagen coated
synthetic graft
coated vascular
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU38196/85A
Other languages
English (en)
Other versions
AU3819685A (en
Inventor
Milos Chvapil
Harmon Hoffman Jr.
Kemal Schankereli
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boston Scientific Scimed Inc
Original Assignee
Meadox Medicals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Meadox Medicals Inc filed Critical Meadox Medicals Inc
Publication of AU3819685A publication Critical patent/AU3819685A/en
Application granted granted Critical
Publication of AU575617B2 publication Critical patent/AU575617B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A61F2/06—Blood vessels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/28—Materials for coating prostheses
    • A61L27/34—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/507—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials for artificial blood vessels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A61F2/06—Blood vessels
    • A61F2002/065—Y-shaped blood vessels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/252—Polypeptides, proteins, e.g. glycoproteins, lipoproteins, cytokines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/412—Tissue-regenerating or healing or proliferative agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/42—Anti-thrombotic agents, anticoagulants, anti-platelet agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/606—Coatings
    • A61L2300/608—Coatings having two or more layers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Vascular Medicine (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pulmonology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Materials For Medical Uses (AREA)
  • Prostheses (AREA)
AU38196/85A 1984-01-30 1985-01-30 Collagen coated vascular synthetic graft drug delivery system Ceased AU575617B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US57509184A 1984-01-30 1984-01-30
US575091 1984-01-30

Publications (2)

Publication Number Publication Date
AU3819685A AU3819685A (en) 1985-08-08
AU575617B2 true AU575617B2 (en) 1988-08-04

Family

ID=24298898

Family Applications (1)

Application Number Title Priority Date Filing Date
AU38196/85A Ceased AU575617B2 (en) 1984-01-30 1985-01-30 Collagen coated vascular synthetic graft drug delivery system

Country Status (11)

Country Link
JP (1) JPH0636817B2 (fr)
AU (1) AU575617B2 (fr)
BE (1) BE901611A (fr)
CA (1) CA1250235A (fr)
CH (1) CH670380A5 (fr)
DE (1) DE3503126C2 (fr)
FR (1) FR2558720B1 (fr)
GB (2) GB2153235B (fr)
IL (1) IL74180A (fr)
NL (1) NL193263C (fr)
SE (1) SE464009B (fr)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4699141A (en) * 1986-01-16 1987-10-13 Rhode Island Hospital Neovascularization
DE3608158A1 (de) * 1986-03-12 1987-09-17 Braun Melsungen Ag Mit vernetzter gelatine impraegnierte gefaessprothese und verfahren zu ihrer herstellung
FI83729C (fi) * 1987-11-26 1991-08-26 Biocon Oy Kirurgisk implantat.
US6004346A (en) * 1990-02-28 1999-12-21 Medtronic, Inc. Intralumenal drug eluting prosthesis
US5545208A (en) * 1990-02-28 1996-08-13 Medtronic, Inc. Intralumenal drug eluting prosthesis
EP0470246B1 (fr) * 1990-02-28 1995-06-28 Medtronic, Inc. Prothese pour l'elution intraluminale d'un medicament
CS277367B6 (en) * 1990-12-29 1993-01-13 Krajicek Milan Three-layered vascular prosthesis
CA2074924A1 (fr) * 1991-08-05 1993-02-06 Matthew E. Hermes Methode et composition pour le traitement d'instruments chirurgicaux resorbables
DE4222380A1 (de) * 1992-07-08 1994-01-13 Ernst Peter Prof Dr M Strecker In den Körper eines Patienten perkutan implantierbare Endoprothese
US6334872B1 (en) 1994-02-18 2002-01-01 Organogenesis Inc. Method for treating diseased or damaged organs
DE69535595T2 (de) * 1994-02-18 2008-06-05 Organogenesis, Inc., Canton Verfahren zur Herstellung einer Bio-umbaubaren Transplantatprothese aus Kollagen
FR2722678B1 (fr) * 1994-07-25 1996-12-27 Braun Celsa Sa B Prothese medicale a embranchement utilisable pour le traitement des anevrismes, dispositif comprenant une telle prothese
US5665114A (en) * 1994-08-12 1997-09-09 Meadox Medicals, Inc. Tubular expanded polytetrafluoroethylene implantable prostheses
US20020095218A1 (en) 1996-03-12 2002-07-18 Carr Robert M. Tissue repair fabric
DE19521642C2 (de) * 1995-06-14 2000-11-09 Aesculap Ag & Co Kg Implantat, seine Verwendung in der Chirurgie und Verfahren zu seiner Herstellung
US6177609B1 (en) * 1997-03-10 2001-01-23 Meadox Medicals, Inc. Self-aggregating protein compositions and use as sealants
SE514944C2 (sv) 1997-12-30 2001-05-21 Lars Sunnanvaeder Apparatur för terapeutisk behandling av ett blodkärl
US6129757A (en) 1998-05-18 2000-10-10 Scimed Life Systems Implantable members for receiving therapeutically useful compositions
EP1083843A4 (fr) 1998-06-05 2005-06-08 Organogenesis Inc Protheses vasculaires greffees obtenues par genie biomedical
US6369039B1 (en) 1998-06-30 2002-04-09 Scimed Life Sytems, Inc. High efficiency local drug delivery
US6797743B2 (en) 2000-09-27 2004-09-28 Michigan Biotechnology Institute Antimicrobial polymer
US6939554B2 (en) 2002-02-05 2005-09-06 Michigan Biotechnology Institute Antimicrobial polymer
US7204940B2 (en) 2002-03-20 2007-04-17 Michigan Biotechnology Institute Conductive polymer-based material
US6951902B2 (en) 2002-08-16 2005-10-04 Michigan Biotechnology Institute Two dimensional polymer that generates nitric oxide
US6923996B2 (en) 2003-05-06 2005-08-02 Scimed Life Systems, Inc. Processes for producing polymer coatings for release of therapeutic agent
US7329531B2 (en) * 2003-12-12 2008-02-12 Scimed Life Systems, Inc. Blood-tight implantable textile material and method of making
JP4719133B2 (ja) * 2006-11-21 2011-07-06 株式会社東京機械製作所 咥折装置
DE102009037134A1 (de) 2009-07-31 2011-02-03 Aesculap Ag Tubuläres Implantat zum Ersatz von natürlichen Blutgefäßen

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3272204A (en) * 1965-09-22 1966-09-13 Ethicon Inc Absorbable collagen prosthetic implant with non-absorbable reinforcing strands
WO1983003536A1 (fr) * 1982-04-19 1983-10-27 Massachusetts Inst Technology Prothese multi-couches bioremplacable de vaisseaux sanguins

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1185332B (de) * 1961-03-01 1965-01-14 Ethicon Inc Chirurgische Prothese
DE1491218C3 (de) * 1963-06-15 1973-01-04 Spofa Sdruzheni Podniku Pro Zdravotnickou Vyrobu, Prag Blutgefäßprothese und Verfahren zur Herstellung derselben
US3479670A (en) * 1966-10-19 1969-11-25 Ethicon Inc Tubular prosthetic implant having helical thermoplastic wrapping therearound
DE1566358B2 (de) * 1967-03-09 1977-04-21 Meadox Medicals, Inc., Haiedon, NJ. (V.StA.) Gefaessprothese fuer chirurgische zwecke
DE1766340A1 (de) * 1967-05-19 1971-07-01 Vyzk Ustav Pletarzsky Textil-Kollagenprothese
FR2029155A5 (en) * 1969-01-15 1970-10-16 Mo Med I Prosthetic vessels of high biological - permeability
US3688317A (en) * 1970-08-25 1972-09-05 Sutures Inc Vascular prosthetic
US3928653A (en) * 1975-02-05 1975-12-23 Tee Pak Inc Collagen slurry containing partial fatty acid esters of glycerin
DE2601289C3 (de) * 1976-01-15 1978-07-13 B. Braun Melsungen Ag, 3508 Melsungen Verfahren zum Abdichten von synthetischen Velours-Gefäßprothesen
DE2843963A1 (de) * 1978-10-09 1980-04-24 Merck Patent Gmbh Im koerper resorbierbare geformte masse auf basis von kollagen und ihre verwendung in der medizin
SU904693A1 (ru) * 1980-05-12 1982-02-15 Первый Московский Ордена Ленина И Ордена Трудового Красного Знамени Медицинский Институт Им. И.М.Сеченова Протез сосуда
US4416028A (en) * 1981-01-22 1983-11-22 Ingvar Eriksson Blood vessel prosthesis
US4546500A (en) * 1981-05-08 1985-10-15 Massachusetts Institute Of Technology Fabrication of living blood vessels and glandular tissues

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3272204A (en) * 1965-09-22 1966-09-13 Ethicon Inc Absorbable collagen prosthetic implant with non-absorbable reinforcing strands
WO1983003536A1 (fr) * 1982-04-19 1983-10-27 Massachusetts Inst Technology Prothese multi-couches bioremplacable de vaisseaux sanguins

Also Published As

Publication number Publication date
AU3819685A (en) 1985-08-08
GB2187192B (en) 1988-12-14
GB8502156D0 (en) 1985-02-27
GB8708756D0 (en) 1987-05-20
JPH0636817B2 (ja) 1994-05-18
FR2558720A1 (fr) 1985-08-02
DE3503126C2 (de) 1996-05-15
SE464009B (sv) 1991-02-25
NL193263C (nl) 1999-05-06
BE901611A (fr) 1985-05-17
CH670380A5 (fr) 1989-06-15
SE8500422L (sv) 1985-09-02
FR2558720B1 (fr) 1989-10-20
SE8500422D0 (sv) 1985-01-30
IL74180A0 (en) 1985-04-30
IL74180A (en) 1992-06-21
DE3503126A1 (de) 1985-08-01
NL193263B (nl) 1999-01-04
GB2153235A (en) 1985-08-21
JPS6192672A (ja) 1986-05-10
GB2187192A (en) 1987-09-03
NL8500239A (nl) 1985-08-16
GB2153235B (en) 1988-12-14
CA1250235A (fr) 1989-02-21

Similar Documents

Publication Publication Date Title
AU575617B2 (en) Collagen coated vascular synthetic graft drug delivery system
AU576630B2 (en) Drug delivery system
AU2880489A (en) Vascular graft
AU3933085A (en) Closed drug delivery system
AU2164188A (en) Improved antimicrobial coated implants
AU1817088A (en) Multi-layer delivery system
AU6820687A (en) Drug delivery system
AU1269788A (en) Pectin delivery system
AU7331087A (en) Pulsatile drug delivery system
AU575268B2 (en) Coated suture
AU3664184A (en) Flavor delivery system
AU577826B2 (en) Collagen-coated synthetic vascular graft
AU8263987A (en) Pharmaceutical Delivery Systems
AU573012B2 (en) Collagen coated bone implant
AU541562B2 (en) Vascular prosthesis
AU587925B2 (en) Hanky delivery system
AU4304189A (en) Powder sprayer with automatic powder supply system
AU6310886A (en) Electrostatically produced vascular graft
AU7291587A (en) Coated veterinary implants
AU1867388A (en) Shelf conveying system
AU6974087A (en) Vascular stent
AU620984B2 (en) Endovascular stent and delivery system
AU1464588A (en) Sheep delivery system
AU1079188A (en) Air-to-surface delivery system
AU619788C (en) Redox systems for brain-targeted drug delivery

Legal Events

Date Code Title Description
MK14 Patent ceased section 143(a) (annual fees not paid) or expired